Stockreport

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Foghorn Therapeutics Inc.  (FHTX) 
PDF Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a leading biotech mutual fund in a transaction that will c [Read more]